NSE filing, NSE: AKG. Summary written from the filing by ALFA Finder's alert engine.
AKG Exim Ltd: key numbers
- Share price
- ₹9.29
- Market cap
- ₹29.52 Cr
- Revenue (annual)
- ₹87.01 Cr
- Net profit (annual)
- ₹0.36 Cr
- P/E (TTM)
- 79.3×Sector 36.4×
- Promoter holding
- 50.69%+0.00% QoQ
- FII holding
- 1.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AKG Exim Ltd
All →AKG Exim Annual General Meeting
AKG Exim Limited conducted its 21st Annual General Meeting on September 26, 2026. Shareholders transacted seven agenda items, including financial statement adoption and director appointments.
AKG Exim Promoter Selling (Off-Market): ₹9.54 Cr
AKG Exim Limited promoter Mahima Goel sold a 23.10% stake to Kalapi Vinit Nagada via an off-market SPA. The transaction was completed for a consideration of Rs. 9.54 Crore.
- Value
- ₹9.54 Cr
AKG Exim Annual General Meeting
Akg Exim Limited has issued the notice for its 21st Annual General Meeting to be held on September 26, 2026. Agenda items include director appointments and financial adoption.
AKG Exim Management Change
AKG Exim Limited has appointed Mr. Ajay Kumar Prajapati as the Secretarial Auditor of the Company, effective August 12, 2026.
AKG Exim Q1 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% YoY
AKG Exim Ltd reported revenue from operations of ₹20.7 Cr (-27.6% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr · +0.0% YoY
AKG Exim Board Meeting Date
AKG Exim Limited has scheduled a board meeting on August 12, 2026. The board will consider unaudited standalone and consolidated financial results for the June quarter.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.